Hindustan Biosciences' Board approved the financial results for the quarter, reporting a profit of 0.014 Cr on total revenue of 0.3350 Cr.

The company announced the resignation of Mr. Devanshu Ravinder Dange as Company Secretary and Compliance Officer, and promptly appointed Mr. Shailendra Vyas to the role.

Additionally, the Board approved the notice for the 33rd Annual General Meeting, along with the Directors' and Corporate Governance reports, and set its date and venue.

These updates cover recent financial performance and key governance changes.